Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-02-21 @ 6:53 PM
Study NCT ID:
NCT00327327
Status:
COMPLETED
Last Update Posted:
2010-09-15
First Post:
2006-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
Sponsor:
AmpliMed Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AMP-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Evan Hersh, VP Medical Affairs
Old Organization:
AmpliMed Corporation